Roniel Cabrera, M.D.

Roniel Cabrera, M.D., M.S.

(352) 273-9400

Current patients:
Log in to MyUFHealth

Publications

Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate.
European journal of gastroenterology & hepatology
2021

Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
Hepatology (Baltimore, Md.)
2021

Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
Digestive diseases and sciences
2021

Advances in the management of cholangiocarcinoma.
World journal of hepatology
2021

A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC.
Hepatology communications
2021

A Focused Review on Recent Advances in the Diagnosis and Treatment of Viral Hepatitis.
Gastroenterology research
2021

Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation
American Journal of Clinical Oncology-Cancer Clinical Trials
2020

Down staging of hepatocellular carcinoma-can we push the boundaries?
Hepatobiliary surgery and nutrition
2020

Utility of Inflammatory Markers in Predicting Hepatocellular Carcinoma Survival after Liver Transplantation.
BioMed research international
2019

Thermal ablation versus wedge or segmental resection in patients with early stage hepatocellular carcinoma: a population survival analysis.
HPB : the official journal of the International Hepato Pancreato Biliary Association
2019

Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies.
Journal of gastrointestinal cancer
2018

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.
Journal of hepatology
2018

Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Abdominal radiology (New York)
2018

Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.
Clinics in liver disease
2017

Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Current problems in diagnostic radiology
2017

Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma.
Case reports in hepatology
2017

Transportal Radioembolization as Salvage Hepatocellular Carcinoma Therapy to Maintain Liver Transplant Candidacy.
Journal of vascular and interventional radiology : JVIR
2015

Current and future treatments for hepatocellular carcinoma.
World journal of gastroenterology
2015

Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Liver international : official journal of the International Association for the Study of the Liver
2014

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.
Oncology reports
2013

The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma.
Alimentary pharmacology & therapeutics
2013

OPA1 downregulation is involved in sorafenib-induced apoptosis in hepatocellular carcinoma.
Laboratory investigation; a journal of technical methods and pathology
2013

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology
2013

Management of liver cirrhosis in patients with hepatocellular carcinoma.
Chinese clinical oncology
2013

Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
Cancer immunology, immunotherapy : CII
2013

Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.
Digestive diseases and sciences
2013

CC genotype donors for the interleukin-28B single nucleotide polymorphism are associated with better outcomes in hepatitis C after liver transplant.
Liver international : official journal of the International Association for the Study of the Liver
2013

Another armed CD4(+) T cell ready to battle hepatocellular carcinoma.
Hepatology (Baltimore, Md.)
2013

The Impact of Pre Transplant Transarterial Therapy in Hepatocellular Carcinoma
Higher Education Policy
2012

The Impact of Pre Transplant Transarterial Therapy in Hepatocellular Carcinoma
Higher Education Policy
2012

Systemic targeted therapy beyond sorafenib.
Clinical liver disease
2012

Serum Levels of Soluble Cd25 as a Marker for Hepatocellular Carcinoma
Oncology letters
2012

Rare case of adult undifferentiated (embryonal) sarcoma of the liver treated with liver transplantation: excellent long-term survival.
Case reports in hepatology
2012

Incidentally Discovered Hcc (Ihcc) in Explant Liver- Clinical and Histopathologic Features and Outcome
Higher Education Policy
2012

Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.
American journal of clinical oncology
2012

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics.
Hepatic medicine : evidence and research
2012

The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma.
Alimentary pharmacology & therapeutics
2011

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
Alimentary pharmacology & therapeutics
2011

Klatskin Tumor- Clinical Outcome and Prognostic Factors
Higher Education Policy
2011

Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.
Laboratory investigation; a journal of technical methods and pathology
2011

Different radiosensitivity of CD4(+)CD25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitro.
International journal of radiation biology
2011

Boceprevir for chronic HCV genotype 1 infection.
The New England journal of medicine
2011

Antiviral Effect of Sorafenib in Hcv Related Hepatocellular Carcinoma
Higher Education Policy
2011

A Sustained Viral Response Dramatically Improves Survival in Patients With Hepatitis C Infection After Liver Transplant

2011

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Digestive diseases and sciences
2010

The Impact of Transarterial Therapy in Recurrent Hepatocellular Carcinoma After Liver Transplant
Higher Education Policy
2010

The Impact of Preservation Injury On Accelerated Hepatitis C Recurrence After Liver Transplantation
Higher Education Policy
2010

Review article: the management of hepatocellular carcinoma.
Alimentary pharmacology & therapeutics
2010

Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.
Scandinavian journal of immunology
2010

Incidence of Hepatocellular Carcinoma in Florida: Distribution in Racial Subpopulations
Higher Education Policy
2010

Imaging of hepatocellular carcinoma and early diagnosis.
Minerva medica
2010

Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25).
Digestive diseases and sciences
2010

Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
2009

The natural history of hepatitis C cirrhosis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
2009

Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation.
PloS one
2009

Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells.
Cell biology international
2009

Fenofibrate Improves Liver Biochemistries in Primary Biliary Cirrhosis
Higher Education Policy
2009

Using Immune Functional Assay To Differentiate Acute Cellular Rejection From Recurrent Hepatitis C in Liver Transplant Patients
Higher Education Policy
2008

The Natural History of Hcv-Related Cirrhosis After Liver Transplantation
Journal of Hepatology
2008

Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients With Hepatitis C
American Journal of Transplantation
2008

Hepatocellular Carcinoma Is Associated With An Impaired Cd4 T Cell Immune Response
Journal of Hepatology
2008

Cyclosporine Helps To Achieve a Higher Svr in Patients Receiving Peg-Interferon/Ribavirin for Recurrent Hepatitis C After Liver Transplantation: Final Analysis of a Randomized-Controlled Study
Journal of Hepatology
2008

The "C" of viral hepatitis in children.
Seminars in liver disease
2007

New Inhibitors of the HCV Life Cycle
Hot Topics in Viral Hepatitis
2007

Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells.
Laboratory investigation; a journal of technical methods and pathology
2007

Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
2006

One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
2004

An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
Hepatology (Baltimore, Md.)
2004

Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.
Hepatology (Baltimore, Md.)
2003